Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization
NCT06180993
·
clinicaltrials.gov ↗
RECRUITING
Status
42000
Enrollment
OTHER
Sponsor class
Conditions
RSV Infection
Interventions
BIOLOGICAL:
Nirsevimab
Sponsor
Federico Martinón Torres